General Announcement::GPL Announces Poster Presentations on GBR 1302 and GBR 1342 at the 2018 ASCO Annual Meeting

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-May-2018 11:17:22
Status
New
Announcement Sub Title
GPL Announces Poster Presentations on GBR 1302 and GBR 1342 at the 2018 ASCO Annual Meeting
Announcement Reference
SG180528OTHR9P39
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
28/05/2018 09:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark Pharmaceuticals Announces Poster Presentations on GBR 1302 and GBR 1342, HER2xCD3 and CD38xCD3 Bispecific Antibodies, at the 2018 ASCO Annual Meeting.

Attachments

PR_28052018.pdf
Total size =3228K